Woolsey Pharmaceuticals
Woolsey Pharmaceuticals: Innovating treatments for challenging diseases, accelerating global health solutions.
Founded
2019Woolsey Pharmaceuticals: Innovating treatments for challenging diseases, accelerating global health solutions.
Woolsey Pharmaceuticals, founded in 2019, is dedicated to reinventing treatments for some of the world's most challenging diseases, with a particular focus on neurodegenerative conditions. The company aims to accelerate the delivery of innovative medicines to improve global health outcomes. Headquartered in an undisclosed location, Woolsey Pharmaceuticals offers a range of cutting-edge pharmaceutical products and services designed to push the boundaries of medical science.
Notable figures associated with Woolsey Pharmaceuticals include leading scientists and industry experts who contribute to its pioneering research and development efforts. The company has garnered attention from prominent investors in the biotech sector, enabling it to achieve significant milestones in drug development. Woolsey's impact is marked by its commitment to advancing medical science and providing expanded access to groundbreaking treatments, positioning itself as a key player in the fight against debilitating diseases.
Companies similar to Woolsey Pharmaceuticals include Chase Therapeutics, Osprey Pharmaceuticals USA, Wellesley Pharmaceuticals and Pharmos.
Woolsey Pharmaceuticals was founded in 2019.
Woolsey Pharmaceuticals' headquarters is located in New York City, NY, US.
Woolsey Pharmaceuticals' most recent funding round was for $19.7M (USD) in October 2021.
As of Oct 15, 2021, Woolsey Pharmaceuticals has disclosed funding of $28.3M (USD). Undisclosed round amounts are excluded.
Woolsey Pharmaceuticals has 9 employees as of Feb 5, 2024.
Pharmos
pharmoscorp.com
